SDGR
Schrodinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$23.12
+2.30%Year over year
Reported trailing growth
- Revenue
- +8.9%
- EBITDA
- +75.1%
- EBIT
- +20.5%
- EPS
- +70.2%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -5.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +12.2%
- EBITDA
- +46.4%
- EBIT
- +20.3%
- Net income
- +44.8%
- EPS
- +45.1%
- Free cash flow
- +107.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026